Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pulmonology

Quality of Life and Symptom Management

At a Glance

Managing Idiopathic Pulmonary Fibrosis (IPF) involves more than just slowing lung scarring. Early palliative care, pulmonary rehabilitation, and targeted therapies can significantly improve your quality of life by relieving chronic cough, easing shortness of breath, and supporting mental health.

Living with Idiopathic Pulmonary Fibrosis (IPF) is about more than just managing a disease; it is about managing your daily life and comfort. While medical treatments focus on slowing the scarring in your lungs, other therapies are designed to help you breathe easier and stay active [1].

The Role of Palliative Care

It is a common misconception that palliative care is only for the end of life (hospice). In the context of IPF, palliative care is “supportive care” that should be introduced early in your journey [1][2].

  • Symptom Management: Its primary goal is to relieve the burden of symptoms like chronic cough and breathlessness (dyspnea) [3].
  • Holistic Support: Palliative care teams work alongside your pulmonologist to address the physical, emotional, and social challenges of living with a progressive condition [2].

Managing Your Symptoms

Two of the most challenging symptoms of IPF are a persistent dry cough and shortness of breath.

Chronic Cough

The cough in IPF can be physically exhausting and socially isolating [4]. Because it is caused by the scarring itself, typical over-the-counter cough syrups rarely work [5].

  • Pharmacological Options: Your doctor may discuss medications such as low-dose morphine or neuromodulators (like gabapentin), which can help calm the cough reflex [6][7]. While you may associate morphine with hospice or end-of-life care, in this context it is used safely under medical supervision specifically to calm the cough receptors. It requires close monitoring by your care team for side effects like sedation or constipation.
  • Non-Drug Strategies: Speech and language therapy can teach you “cough suppression” techniques to help you gain more control over the urge to cough [4].

Shortness of Breath and Pulmonary Rehab

Pulmonary rehabilitation is one of the most effective ways to manage breathlessness [8]. It involves:

  • Exercise Training: Improving the strength of your muscles so they use oxygen more efficiently [8].
  • Breathing Techniques: Learning how to breathe in a way that maximizes your lung capacity and reduces anxiety during exertion [9].

Monitoring and the 6-Minute Walk Test

Your doctor will use the 6-minute walk test (6MWT) to monitor how the disease is affecting your physical function [10].

  • What it measures: It tracks the distance you can walk in six minutes and how much your oxygen levels (SpO2) drop during that time [10].
  • Why it matters: Your walk distance and oxygen levels are important indicators of your overall stability and can help your team decide when it is time for supplemental oxygen [10][11].

The Psychological Toll

Living with frequent Pulmonary Function Tests (PFTs) and imaging scans can create a significant amount of stress, often called “scanxiety” [12]. It is normal to feel anxious before a test, fearing it might show the disease is progressing [13].

  • Anxiety and Depression: These are common in IPF and are not a sign of weakness—they are a response to the burden of a chronic illness [12].
  • Seeking Support: Talking to a mental health professional who specializes in chronic illness or joining a support group can provide a safe space to process these feelings [14][9]. Managing your mental health is just as important as managing your lung function.

Common questions in this guide

How can palliative care help me manage my IPF?
Palliative care provides early supportive care focused on relieving symptoms rather than end-of-life care. A palliative team works alongside your pulmonologist to manage physical challenges like chronic cough and shortness of breath, as well as emotional stress.
Why don't regular over-the-counter cough syrups work for my IPF cough?
The chronic cough in IPF is caused by the physical scarring of your lungs rather than common respiratory irritants. Your doctor may prescribe specific medications like neuromodulators or low-dose morphine to safely calm the cough reflex, or refer you to speech therapy for cough suppression techniques.
What is the 6-minute walk test and why is it important?
The 6-minute walk test measures how far you can walk in six minutes and monitors how your oxygen levels change during physical exertion. This helps your care team track your overall physical function and decide if you need supplemental oxygen.
How does pulmonary rehabilitation improve shortness of breath?
Pulmonary rehabilitation teaches you specialized breathing techniques to maximize your lung capacity and reduce anxiety during activity. It also includes exercise training to strengthen your muscles so they use oxygen more efficiently.
What is 'scanxiety' and how can I deal with it?
Scanxiety is the normal stress, fear, or anxiety experienced before medical tests like pulmonary function tests or imaging scans. Speaking with a mental health professional or joining a chronic illness support group can help you safely process these feelings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you refer me to a palliative care specialist to help manage my cough and shortness of breath?
  2. 2.What is my current 6-minute walk distance, and how does it compare to my previous tests?
  3. 3.Are there any speech and language therapy programs available to help with my cough suppression?
  4. 4.Given my level of shortness of breath, am I a candidate for low-dose morphine or neuromodulators for symptom relief?
  5. 5.What can we do to manage the 'scanxiety' I feel before my regular monitoring appointments?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Idiopathic Pulmonary Fibrosis.

    Lederer DJ, Martinez FJ

    The New England journal of medicine 2018; (378(19)):1811-1823 doi:10.1056/NEJMra1705751.

    PMID: 29742380
  2. 2

    Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

    van Manen MJ, Geelhoed JJ, Tak NC, Wijsenbeek MS

    Therapeutic advances in respiratory disease 2017; (11(3)):157-169 doi:10.1177/1753465816686743.

    PMID: 28134007
  3. 3

    Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives.

    Graney BA, Lee JS

    Patient related outcome measures 2018; (9()):321-328 doi:10.2147/PROM.S144425.

    PMID: 30288134
  4. 4

    Mechanisms and management of cough in interstitial lung disease.

    Rasheed AZ, Metersky ML, Ghazal F

    Expert review of respiratory medicine 2023; (17(12)):1177-1190 doi:10.1080/17476348.2023.2299751.

    PMID: 38159067
  5. 5

    A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.

    Birring SS, Wijsenbeek MS, Agrawal S, et al.

    The Lancet. Respiratory medicine 2017; (5(10)):806-815 doi:10.1016/S2213-2600(17)30310-7.

    PMID: 28923239
  6. 6

    Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial.

    Wu Z, Spencer LG, Banya W, et al.

    The Lancet. Respiratory medicine 2024; (12(4)):273-280 doi:10.1016/S2213-2600(23)00432-0.

    PMID: 38237620
  7. 7

    The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial.

    Gao R, Xu X, Wang S, et al.

    Trials 2022; (23(1)):165 doi:10.1186/s13063-022-06059-5.

    PMID: 35189953
  8. 8

    Impact of Pulmonary Rehabilitation on Exercise Tolerance and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A SYSTEMATIC REVIEW AND META-ANALYSIS.

    Gomes-Neto M, Silva CM, Ezequiel D, et al.

    Journal of cardiopulmonary rehabilitation and prevention 2018; (38(5)):273-278 doi:10.1097/HCR.0000000000000273.

    PMID: 29351129
  9. 9

    Mood disorder in idiopathic pulmonary fibrosis: response to pulmonary rehabilitation.

    Edwards GD, Polgar O, Patel S, et al.

    ERJ open research 2023; (9(3)) doi:10.1183/23120541.00585-2022.

    PMID: 37228278
  10. 10

    Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study.

    Kim MJ, Nathan SD, Kim HH, Kim HC

    Therapeutic advances in respiratory disease 2024; (18()):17534666241275329 doi:10.1177/17534666241275329.

    PMID: 39175212
  11. 11

    Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil.

    Mancuzo EV, Soares MR, Pereira CAC

    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2018; (44(4)):267-272 doi:10.1590/S1806-37562018000000049.

    PMID: 30328926
  12. 12

    Quality of life in idiopathic pulmonary fibrosis in Latin American countries.

    Aguilar-Duran H, Fernández M, González-García M, et al.

    BMC pulmonary medicine 2025; (25(1)):36 doi:10.1186/s12890-025-03506-2.

    PMID: 39856586
  13. 13

    Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis.

    Lee YJ, Choi SM, Lee YJ, et al.

    PloS one 2017; (12(9)):e0184300 doi:10.1371/journal.pone.0184300.

    PMID: 28892504
  14. 14

    Managing Dyspnea in Individuals With Idiopathic Pulmonary Fibrosis.

    Fenwick KE, Swan BA

    Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association 2020; (22(6)):447-455 doi:10.1097/NJH.0000000000000687.

    PMID: 32956191

This page provides general information about managing symptoms and improving quality of life with idiopathic pulmonary fibrosis (IPF). It is not a substitute for professional medical advice; always consult your pulmonologist before starting or changing any treatments.

Get notified when new evidence is published on Idiopathic pulmonary fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.